Xeris Biopharma Holdings
Utility Patent Applications

Last updated:

List of all Xeris Biopharma Holdings patents 9 in total

Status Patent
Application
Utility: PRECIPITATION RESISTANT SMALL MOLECULE DRUG FORMULATIONS External link
Filling date: 8 Nov 2025 Issue date: 31 Mar 2022
Application
Utility: STABLE SUSTAINED RELEASE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME External link
Filling date: 8 Nov 2025 Issue date: 30 Dec 2021
Application
Utility: STABLE FORMULATIONS FOR PARENTERAL INJECTION OF PEPTIDE DRUGS External link
Filling date: 8 Nov 2025 Issue date: 14 Oct 2021
Application
Utility: TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA USING MINI-DOSE STABLE GLUCAGON External link
Filling date: 8 Nov 2025 Issue date: 4 Feb 2021
Application
Utility: TREATMENT OF EXERCISE-INDUCED HYPOGLYCEMIA IN TYPE 1 AND INSULIN USING TYPE 2 DIABETES External link
Filling date: 8 Nov 2025 Issue date: 14 Jan 2021
Application
Utility: STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME External link
Filling date: 8 Nov 2025 Issue date: 3 Dec 2020
Application
Utility: STABLE FORMULATIONS FOR PARENTERAL INJECTION OF SMALL MOLECULE DRUGS External link
Filling date: 8 Nov 2025 Issue date: 26 Nov 2020
Application
Utility: Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents External link
Filling date: 8 Nov 2025 Issue date: 9 Jul 2020
Application
Utility: METHODS FOR TREATING CONGENITAL HYPERINSULINISM External link
Filling date: 8 Nov 2025 Issue date: 14 May 2020

Showing 1 to 9 of 9 patents.